CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-05 | Cockroft Bettina M. Director | Grant or award · Stock Option (Right to Buy) | +44,000 | 44,000 | ||
| 2024-06-03 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $4.83 | $15K | 9,600 |
| 2024-05-01 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $4.68 | $15K | 6,400 |
| 2024-04-08 | Carson William H. Director | Purchase 10b5-1 | +3,200 | $6.07 | $19K | 3,200 |
| 2024-02-27 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant or award | +44,963 | 128,777 | ||
| 2024-02-27 | Dananberg Jamie CHIEF MEDICAL OFFICER | Grant or award | +44,963 | 78,442 | ||
| 2024-02-27 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Grant or award | +44,963 | 122,733 | ||
| 2024-02-27 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award | +44,963 | 106,200 | ||
| 2024-02-27 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +44,963 | 131,542 | ||
| 2024-02-20 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Sale | −2,604 | $5.51 | $14K | 72,471 |
| 2024-02-20 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Sale | −1,951 | $5.48 | $11K | 85,641 |
| 2024-02-20 | Lew Jennifer EVP & CHIEF FINANCIAL OFFICER | Sale | −2,593 | $5.53 | $14K | 82,058 |
| 2024-02-16 | Love Douglas PRESIDENT AND CEO | Grant or award · Stock Option (Right to Buy) | +656,200 | 656,200 | ||
| 2024-02-16 | Dananberg Jamie CHIEF MEDICAL OFFICER | Grant or award | +39,000 | 39,000 | ||
| 2024-02-16 | Dananberg Jamie CHIEF MEDICAL OFFICER | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-02-16 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant or award | +39,000 | 89,329 | ||
| 2024-02-16 | ARTIS DEAN RICHARD EVP & CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-02-16 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award | +39,000 | 75,075 | ||
| 2024-02-16 | Yednock Ted EVP & CHIEF INNOVATION OFFICER | Grant or award · Stock Option (Right to Buy) | +160,000 | 160,000 | ||
| 2024-02-16 | Overdorf Michael EVP & CHIEF BUSINESS OFFICER | Grant or award | +39,000 | 87,592 |
Page 6 of 15 · 292 trades